Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
2.545
+0.095 (3.86%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $17.79 million as of October 29, 2024. Its market cap has decreased by -55.40% in one year.
Market Cap
17.79M
Enterprise Value
73.49M
1-Year Change
-55.40%
Ranking
Category
Stock Price
$2.54
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has decreased from $110.60M to $17.79M, a decrease of -83.91%. That is a compound annual growth rate of -16.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 17.20M | -60.00% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NanoViricides | 17.66M |
| GeoVax Labs | 17.65M |
| Meihua International Medical Technologies | 17.62M |
| HCW Biologics | 17.49M |
| Cumberland Pharmaceuticals | 17.20M |
| AIM ImmunoTech | 16.91M |
| Can-Fite BioPharma | 16.70M |
| Synlogic | 16.61M |